Segmentation by application and analysis of women ’ s health market covers Postmenopausal osteoporosis , Infertility , Endometriosis , Contraceptives , Menopause , Polycystic ovary syndrome ( PCOS ). Endometriosis is a problem affecting a woman ’ s uterus ; the place where a baby grows when a woman is pregnant . The misplaced tissue can cause pain , infertility , and very heavy periods . Polycystic ovary syndrome happens when a woman ’ s ovaries or adrenal glands produce more male hormones than normal .
Women with PCOS are at higher risk of developing diabetes and heart disease . Women who can get pregnant but unable to stay pregnant is also considered as infertile . About 10 % ( 6.1 million ) of women in United States aged 15-44 years have difficulty getting pregnant or staying pregnant . A woman has reached menopause when she has not had a period for 12 months in a row ( 45-55 age ). Menopause happens because the woman ’ s ovary stops producing the hormones estrogen and progesterone .
Contraception is a method of birth control available to prevent unintended pregnancy . Osteoporosis is of major concern among post-menopausal women and this disease is projected to affect around 20 percent of postmenopausal women . The disease is characterized by substantial loss of bone mass and increasing the risk of serious fractures . Currently the menopause therapeutics market is determined by hormone therapeutics . In 2015 , the postmenopausal osteoporosis segment conquered the market and accounted for more than 37 % of the market share .
Browse Full Research Report @ https :// www . millioninsights . com / industry-reports / womens-health-market
Market size by drug class includes Evista , Xgeva , Mirena , Zometa , Minastrin 24FE , Nuvaring , Forteo , Premarin , Actonel , Ortho-Tri-Cy LO 28 , and Reclast . On the basis of geography , women ’ s health therapeutics market size comprises four major regions : North America , Europe , Asia Pacific , and Rest of the World . North America and Europe are the foremost markets for women health therapeutics . This is because of increased awareness regarding women health . Contraception and fertility control are supported by the governments of developing countries such as India and China to curb the growing population . This trend is expected to show positive growth of women ’ s health market from 2014 to 2025 . The key players of women ’ s health market are Allergan , Bayer Healthcare , Merck , Pfizer , Teva Pharmaceuticals , Agile Therapeutics , Amgen , Apothecus Pharmaceutical , AstraZeneca , Blairex Laboratories , Bristol-Myers Squibb , Ferring International Center .
Market Segmentation
Application of Women ’ s Health Outlook ( Revenue , USD Million , 2014 - 2025 )
• Postmenopausal Osteoporosis
• Infertility